Clinical Trials in Michigan

Showing 4301-4320 of 16,154 trials

Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery

NCT07009340

This study is a retrospective chart abstraction for subjects who were enrolled in REN-004. As a retrospective study, all data will be abstracted from the medical records.

Post-discharge Outcomes

Renibus Therapeutics, Inc.200 participantsStarted Nov 2023

Huntsville, Alabama, United States • Fort Wayne, Indiana, United States • Midland, Michigan, United States +1 more locations

Active Not RecruitingPhase 230 miles

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NCT04533451

This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with or without chemotherapy may shrink the tumor in older patients with non-small cell lung cancer.

Metastatic Lung AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Adenocarcinoma+4 more

Alliance for Clinical Trials in Oncology101 participantsStarted Nov 2020

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +502 more locations

Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Find Trials by Condition in Michigan

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

Efficacy-Implementation Study for PC CARES in Rural Alaska

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Multi-Center Study of ManNAc for GNE Myopathy

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD